Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice
Eriya Kenjo,
Hiroyuki Hozumi,
Yukimasa Makita,
Kumiko A. Iwabuchi,
Naoko Fujimoto,
Satoru Matsumoto,
Maya Kimura,
Yuichiro Amano,
Masataka Ifuku,
Youichi Naoe,
Naoto Inukai and
Akitsu Hotta ()
Additional contact information
Eriya Kenjo: T-CiRA Discovery, Takeda Pharmaceutical Company Limited
Hiroyuki Hozumi: T-CiRA Discovery, Takeda Pharmaceutical Company Limited
Yukimasa Makita: T-CiRA Discovery, Takeda Pharmaceutical Company Limited
Kumiko A. Iwabuchi: Takeda-CiRA Joint Program
Naoko Fujimoto: Takeda-CiRA Joint Program
Satoru Matsumoto: Takeda-CiRA Joint Program
Maya Kimura: Takeda Pharmaceutical Company Limited
Yuichiro Amano: Takeda Pharmaceutical Company Limited
Masataka Ifuku: Takeda-CiRA Joint Program
Youichi Naoe: Takeda-CiRA Joint Program
Naoto Inukai: T-CiRA Discovery, Takeda Pharmaceutical Company Limited
Akitsu Hotta: Takeda-CiRA Joint Program
Nature Communications, 2021, vol. 12, issue 1, 1-13
Abstract:
Abstract Genome editing therapy for Duchenne muscular dystrophy (DMD) holds great promise, however, one major obstacle is delivery of the CRISPR-Cas9/sgRNA system to skeletal muscle tissues. In general, AAV vectors are used for in vivo delivery, but AAV injections cannot be repeated because of neutralization antibodies. Here we report a chemically defined lipid nanoparticle (LNP) system which is able to deliver Cas9 mRNA and sgRNA into skeletal muscle by repeated intramuscular injections. Although the expressions of Cas9 protein and sgRNA were transient, our LNP system could induce stable genomic exon skipping and restore dystrophin protein in a DMD mouse model that harbors a humanized exon sequence. Furthermore, administration of our LNP via limb perfusion method enables to target multiple muscle groups. The repeated administration and low immunogenicity of our LNP system are promising features for a delivery vehicle of CRISPR-Cas9 to treat skeletal muscle disorders.
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (4)
Downloads: (external link)
https://www.nature.com/articles/s41467-021-26714-w Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-26714-w
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-021-26714-w
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().